Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07256808 · ClinicalTrials.gov registry record · NA
Medial Tibial Stress Syndrome Prevention
A NA study, sponsored by Rowan University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT07256808: Completed NA study, sponsored by Rowan University.
NCT07256808 is a NA study that has completed, run by Rowan University. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07256808, a NA study, has completed, sponsored by Rowan University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This randomized controlled trial investigated whether a 10-week heavy resistance training program reduced the incidence of medial tibial stress syndrome (MTSS) in collegiate indoor track and field athletes. Twenty-six athletes from Rowan University were randomly assigned to a treatment group (resistance training plus regular training) or a control group (regular training only). Muscle mechanical properties-including tone, stiffness, elasticity, stress relaxation time, and creep-were measured by MyotonPro device (non-invasive) at baseline, post-intervention, and at the end of the season. A 10-week observational follow-up during the indoor season included weekly MTSS symptom surveys. Differences in MTSS incidence and muscle properties were analyzed between groups.
Primary Outcome
Medial Tibial Stress Syndrome (MTSS) Score Survey
Interventions
- OTHER Resistance Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-09-14 |
| Est. Completion | 2024-02-14 |
| Phase | NA |
What the finished NCT07256808 record still lists
NCT07256808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Resistance Training is the first listed.
NCT07256808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07256808 about?
NCT07256808 is a clinical study titled "Medial Tibial Stress Syndrome Prevention". This randomized controlled trial investigated whether a 10-week heavy resistance training program reduced the incidence of medial tibial stress syndrome (MTSS) in collegiate indoor track and field athletes. Twenty-six athletes from Rowan University were randomly assigned to a treatment group (resist...
What is the current status of trial NCT07256808?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-09-14. Estimated completion is 2024-02-14.
What interventions are being tested in trial NCT07256808?
The interventions under investigation include: Resistance Training (OTHER).
Who is sponsoring clinical trial NCT07256808?
This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07256808's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI